No Hiding Bogus Coronavirus Claims From US Regulators In Social Media Or With Vague Terms
Executive Summary
“I don’t know if there’s a misconception that a different set of adverting rules apply to social media," says FTC attorney Christine DeLorme during FDLI conference. The FTC also sees "a lot of attempts at disclaimers. They might say, ‘Of course there’s no cure for COVID, but...’"
You may also be interested in...
Spike In Drug Recalls Expected As US FDA Resumes Inspections, Targeting COVID-19-Related Problems
Attorneys and recall consultants say any firm distributing products associated with COVID-19 should expect to receive the highest level of scrutiny as the US FDA resumes inspections and uses its enforcement muscle to prohibit companies from making adulterated products, such as hand sanitizers, or making fraudulent claims.
COVID-19 False Advertising Symptoms In US Exceed FTC’s Prognosis For Number, Variety
FTC Division of Advertising Practices anticipated surge of false ads for consumer health products related to COVID-19 but it didn’t expect quite the number as well as the variety of bogus claims it’s found, says Assistant Director Richard Cleland.
Sun Sets On California Firm: FTC Pandemic Fraud Complaint Follows Criminal Indictment
Golden Sunrise business owner Huu Tieu marketed a package of herbal mixtures branded “Emergency D-Virus Plan of Care” with claims to treat COVID-19, says FTC complaint. Tieu was indicted on criminal charges two weeks before FTC filed complaint.